Spots Global Cancer Trial Database for Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
Official Title: Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
Study ID: NCT05041309
Conditions
Study Description
Brief Summary: The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of Kite study drugs, axicabtagene ciloleucel, brexucabtagene autoleucel, KITE-222, KITE-363, KITE-439, KITE-585, and KITE-718, in participants of Kite-sponsored interventional studies.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
City of Hope, Duarte, California, United States
UC San Diego Moores Cancer Center, La Jolla, California, United States
University of California Los Angeles, Los Angeles, California, United States
Stanford University, Palo Alto, California, United States
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
University of California, San Francisco Medical Center, San Francisco, California, United States
Colorado Blood Cancer Institute, Denver, Colorado, United States
Sylvester Comprehensive Cancer Centre, Miami, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
University of Chicago Medical Center Clinical Laboratories, Chicago, Illinois, United States
Loyola University Medical Center, Maywood, Illinois, United States
University of Iowa, Iowa City, Iowa, United States
The University of Kansas Cancer Center Westwood, Westwood, Kansas, United States
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Karmanos Cancer Center Institute, Detroit, Michigan, United States
Washington University, Saint Louis, Missouri, United States
University of Nebraska, Omaha, Nebraska, United States
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
Montefiore Medical Center, Bronx, New York, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Columbia University Medical Center, New York, New York, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
University of Rochester Medical Center, Rochester, New York, United States
Mayo Clinic, Rochester, New York, United States
DUHS-Duke Blood Cancer Center, Durham, North Carolina, United States
Cleveland Clinic, Cleveland, Ohio, United States
James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States
Tennessee Oncology, PLLC, Nashville, Tennessee, United States
Vanderbilt University, Nashville, Tennessee, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Swedish Cancer Institute, Seattle, Washington, United States
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Princess Margaret Cancer Center - University Health Network, Toronto, , Canada
Vancouver General Hospital, Vancouver, , Canada
Hopital Saint-Louis, Paris, , France
CHU Bordeaux, Hopital Haut-Leveque, Pessac, , France
Hôpital Pontchaillou - CHU de Rennes, Rennes, , France
Universitatsklinikum Carl Gustav Carus, Dresden, , Germany
LMU Klinikum der Universitat Munchen,Med. Klinik und Poliklinik III, München, , Germany
Universitatsklinikum Wurzburg, Med. Klinik und Poliklinik II, Zentrum lnnere Medizin, Wuerzburg, , Germany
Tel Aviv Souraski Medical Center, Tel Aviv, , Israel
Kyushu University Hospital, Fukuoka, , Japan
Kyoto University Hospital, Kyoto, , Japan
Okayama University Hospital, Okayama, , Japan
Hokkaido University Hospital, Sapporo Hokkaido, , Japan
National Cancer Center Hospital, Tokyo, , Japan
Amsterdam Universitair Medische Centra (UMC), Amsterdam, , Netherlands
University Medical Centre Groningen, Groningen, , Netherlands
Erasmus University Medical Centre (MC), Rotterdam, , Netherlands
UMC Utrecht, Utrecht, , Netherlands
The Royal Marsden NHS Foundation Hospital, London, , United Kingdom
Contact Details
Name: Kite Study Director
Affiliation: Kite, A Gilead Company
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
